For the quarter ended March 2024, Boston Scientific (BSX) reported revenue of $3.86 billion, up 13.8% over the same period last year. EPS came in at $0.56, compared to $0.47 in the year-ago quarter.The reported revenue represents a surprise of +4.85% over the Zacks Consensus Estimate of $3.68 billion. With the consensus EPS estimate being $0.51, the EPS surprise was +9.80%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...